XML 9 R4.htm IDEA: XBRL DOCUMENT v3.24.0.1
Condensed Consolidated Statements of Operations (Unaudited) - USD ($)
shares in Thousands, $ in Thousands
3 Months Ended 6 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Dec. 31, 2023
Dec. 31, 2022
Income Statement [Abstract]        
Net revenue $ 122,683 $ 134,048 $ 246,606 $ 277,641
Cost of revenue [1] 115,830 125,510 232,104 256,755
Gross profit 6,853 8,538 14,502 20,886
Operating expenses:        
Product development [1] 7,272 7,174 14,909 14,000
Sales and marketing [1] 3,325 3,166 6,449 6,266
General and administrative [1] 7,651 7,370 14,438 14,689
Operating loss [1] (11,395) (9,172) (21,294) (14,069)
Interest income 166 12 332 19
Interest expense (111) (213) (222) (439)
Other income (expense), net 38 (9) 67 (32)
Loss before income taxes (11,302) (9,382) (21,117) (14,521)
(Provision for) benefit from income taxes (252) 1,403 (1,002) 2,025
Net loss $ (11,554) $ (7,979) $ (22,119) $ (12,496)
Net loss per share:        
Basic $ (0.21) $ (0.15) $ (0.41) $ (0.23)
Diluted [2] $ (0.21) $ (0.15) $ (0.41) $ (0.23)
Weighted-average shares used in computing net loss per share:        
Basic 54,759 53,709 54,612 53,529
Diluted 54,759 53,709 54,612 53,529
[1] Cost of revenue and operating expenses include stock-based compensation expense as follows:
[2] Diluted net loss per share does not reflect any potential common stock relating to stock options, restricted stock units, or shares issuable related to the ESPP due to net loss incurred during the three and six months ended December 31, 2023 and 2022. The assumed issuance of any additional shares would be anti-dilutive.